Well…. We Got the Pullback, Now What?

The  market registered its third consecutive decline on Wednesday with the S&P ending lower by 1.5%. The benchmark index settled below its 50-day moving average (2,067) while the Nasdaq Composite (-2.0%) underperformed throughout the day. The S&P 500 hovered near its flat line during the opening hour, but high-beta groups like biotechnology (IBB, XBI), chipmakers […]

Read More

Biotech Down 5% In Three Days

The stock market registered its second consecutive decline on Tuesday with the S&P 500 retreating 0.6%.  Equity indices traded near their flat lines through the first half of the day before sliding to lows during afternoon action. All ten sectors finished the day in negative territory with technology (-0.3%) registering the slimmest loss. Health care—slumped […]

Read More

The Dollar & Biotech Dip

Equity indices spent the entire Monday session near their flat lines while the Dollar Index (96.86, -1.05) extended the pullback that began late last week. The index fell 1.1% with the greenback giving up 1.4% to the euro (1.0966). We still may have the last week of the quarter dynamic in play, although we didn’t […]

Read More